DrugPatentWatch Database Preview
MENRIUM 5-2 Drug Profile
When do Menrium 5-2 patents expire, and what generic alternatives are available?
The generic ingredient in MENRIUM 5-2 is chlordiazepoxide; estrogens, esterified. There are eight drug master file entries for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.
Summary for MENRIUM 5-2
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | MENRIUM 5-2 at DailyMed |
US Patents and Regulatory Information for MENRIUM 5-2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 5-2 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for MENRIUM 5-2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 5-2 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-002 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
